RUSSO, VINCENZO
 Distribuzione geografica
Continente #
EU - Europa 1.603
AS - Asia 1.565
NA - Nord America 1.106
SA - Sud America 521
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 4.839
Nazione #
RU - Federazione Russa 1.085
US - Stati Uniti d'America 1.040
SG - Singapore 578
CN - Cina 452
BR - Brasile 435
HK - Hong Kong 188
VN - Vietnam 185
SE - Svezia 95
IT - Italia 89
FR - Francia 88
DE - Germania 65
GB - Regno Unito 50
AR - Argentina 33
FI - Finlandia 31
CA - Canada 28
MX - Messico 28
IN - India 25
PL - Polonia 23
ZA - Sudafrica 21
BD - Bangladesh 20
JP - Giappone 20
ID - Indonesia 18
EC - Ecuador 17
AT - Austria 14
ES - Italia 14
IQ - Iraq 13
NL - Olanda 11
PK - Pakistan 11
UA - Ucraina 9
CL - Cile 8
CO - Colombia 8
VE - Venezuela 7
PY - Paraguay 6
SA - Arabia Saudita 6
TR - Turchia 6
EG - Egitto 5
LT - Lituania 5
AE - Emirati Arabi Uniti 4
IE - Irlanda 4
KR - Corea 4
PH - Filippine 4
TW - Taiwan 4
DO - Repubblica Dominicana 3
HN - Honduras 3
IL - Israele 3
KE - Kenya 3
KZ - Kazakistan 3
MA - Marocco 3
PE - Perù 3
SI - Slovenia 3
TN - Tunisia 3
UY - Uruguay 3
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
CY - Cipro 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
JM - Giamaica 2
JO - Giordania 2
KH - Cambogia 2
OM - Oman 2
UZ - Uzbekistan 2
AL - Albania 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.839
Città #
Singapore 281
Dallas 274
Moscow 218
Hong Kong 184
Ashburn 148
San Jose 106
Beijing 80
Lauterbourg 68
Hefei 64
Ho Chi Minh City 56
Shanghai 52
New York 50
São Paulo 39
Lawrence 35
Princeton 35
Hanoi 33
Los Angeles 32
Milan 26
Orem 23
Tokyo 19
Warsaw 19
Johannesburg 18
Munich 16
Helsinki 15
Rio de Janeiro 15
Denver 14
Frankfurt am Main 14
Turku 14
Nuremberg 13
Belo Horizonte 12
Mexico City 12
Poplar 12
The Dalles 12
Boardman 11
Chennai 11
Toronto 11
Washington 11
Haiphong 10
Naples 10
Montreal 9
Porto Alegre 9
Santa Clara 9
Atlanta 8
Biên Hòa 8
Brooklyn 8
Chicago 8
Curitiba 8
Guayaquil 8
Houston 8
Phoenix 8
Amsterdam 7
Boston 7
Brasília 7
Falkenstein 7
Guangzhou 7
Hải Dương 7
London 7
Vienna 7
Bexley 6
Da Nang 6
Dhaka 6
Joinville 6
Maceió 6
Stockholm 6
Thái Nguyên 6
Campinas 5
Lahore 5
Osasco 5
Paris 5
Baghdad 4
Buenos Aires 4
Council Bluffs 4
Dublin 4
Goiânia 4
Guarulhos 4
Hortolândia 4
Phủ Lý 4
Pittsburgh 4
Querétaro 4
Quito 4
Rho 4
Ribeirão Preto 4
Salvador 4
St Louis 4
Teixeira de Freitas 4
Ankara 3
Barnet 3
Blumenau 3
Borgomanero 3
Bragança Paulista 3
Cairo 3
Carney 3
Charlotte 3
Clifton 3
El Progreso 3
Ferrara 3
Fortaleza 3
Ipatinga 3
Juazeiro do Norte 3
Juiz de Fora 3
Totale 2.391
Nome #
Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11–13 2019, Verona, Italy 131
24-hydroxycholesterol participates in pancreatic neuroendocrine tumor development 117
A pilot phase I study combining peptide-based vaccination and NGR-hTNF vessel targeting therapy in metastatic melanoma 113
Bone marrow metastases: a systematic review of a neglected involvement in malignant melanoma 112
Cholesterol: a putative oncogenic driver for DLBCL 111
A dual role for genetically modified lymphocytes in cancer immunotherapy 110
Anorectal melanoma: Clinico-pathological features of a rare and aggressive malignancy in a multicentric study 103
ACQUISITION OF INTACT ALLOGENEIC HUMAN LEUKOCYTE ANTIGEN MOLECULES BY HUMAN DENDRITIC CELLS 102
Cancer immunity and immunotherapy beyond COVID-19 96
Sixth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, 16-18 October 2008 93
Subcutaneous insulin infusion (CSII) in italy: The third national survey 93
Abrogation of prostaglandin E2/EP4 signaling impairs the development of rag1+ lymphoid precursors in the thymus of zebrafish embryos 92
A family of rapidly evolving genes from the sex reversal critical region in Xp21 91
Clinical and immunologic responses in melanoma patients vaccinated with MAGE-A3-genetically modified lymphocytes 91
Sex dimorphism and cancer immunotherapy: May pregnancy solve the puzzle? 88
LIM-domain-only 4 (LMO4) enhances CD8+ T-cell stemness and tumor rejection by boosting IL-21-STAT3 signaling 83
Skin Photodamage and Melanomagenesis: A Comprehensive Review 83
Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15–16, 2020 79
Detection and functional analysis of tumor-derived LXR ligands 79
Goals and objectives of the Italian Network for Tumor Biotherapy (NIBIT) 78
Oxysterols recruit tumor-supporting neutrophils within the tumor microenvironment: The many facets of tumor-derived oxysterols 76
The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies 73
Discovery of 22(S)-23-phenyl-24-norchol-5-en-3β,22-diol (PFM046) as the first-in-class, steroidal, non-sulfated Liver X Receptor antagonist with anticancer activity 72
Immunohistochemical Investigation of Cyclooxygenase-2 Expression in Rabbit Uterine Adenocarcinoma and the Potential Use of COX-2 Inhibitors in Cancer Therapy 71
Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11–13 2018, Milan, Italy 71
Vaccination in human solid tumors: Recent progress in the clinical arena 70
Tumor-derived factors affecting immune cells 70
C24-hydroxylated stigmastane derivatives as Liver X Receptor agonists 69
Cholesterol metabolites and tumor microenvironment: the road towards clinical translation 67
Melanoma in Adolescents and Young Adults (AYAs): An Italian Multi-Centric Retrospective Experience 67
Autologous versus allogeneic cell-based vaccines? 65
T cells as antigen carriers for anti-tumor vaccination 64
Chronic atrophic gastritis (GAC) and Helicobacter pylori infection eradication: a 3 years follow-up 63
Inhibition of CCR7/CCL19 axis in lesional skin is a critical event for clinical remission induced by TNF blockade in patients with psoriasis 61
Preliminary evidences for recruitment of innate responses to rectal cancer cell death elicited by neo-adjuvant radio-chemo therapy 60
Nuclear receptor ligands induce TREM-1 expression on dendritic cells: analysis of their role in tumors 59
A clinical study of a cell-based MAGE-A3 active immunotherapy in advanced melanoma patients 58
The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor promoting neutrophils. 58
Side-Chain Modified Ergosterol and Stigmasterol Derivatives as Liver X Receptor Agonists 56
Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy 55
Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responses 54
il Melanoma 53
In search for novel liver X receptors modulators by extending the structure–activity relationships of cholenamide derivatives 52
MAGE, BAGE and GAGE genes expression in fresh epithelial ovarian carcinomas 52
Modificazioni anatomiche e funzionali nella retinopatia solare 52
Update on vaccines for melanoma patients 50
Expression of MAGE gene family in primary and metastatic human breast cancer. Implications for tumor antigen-specific immunotherapy 49
Identification of novel sense and antisense transcription at the TRPM2 locus in cancer 48
Prognostic significance of cancer-testis gene expression in resected non-small cell lung cancer patients. 48
Prognostic role of liver X receptor-alpha in resected stage II and III non-small-cell lung cancer 47
New-onset uveitis during CTLA-4 blockade therapy with ipilimumab in metastatic melanoma patient 47
Selected natural and synthetic retinoids impair CCR7- and CXCR4-dependent cell migration in vitro and in vivo 46
The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice 46
Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity 45
Tumor-mediated liver X receptor-α activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses 45
Identification of a Promiscuous T-Cell Epitope Encoded by Multiple Members of the MAGE Family 44
The pattern recognition receptor PTX3 is recruited at the synapse between dying and dendritic cells, and edits the cross-presentation of self, viral, and tumor antigens 43
Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response 43
The Hidden (And Lazy) TCR 43
The in vivo targeting of tumor antigens to DCs by administration of transduced autologous lymphocytes results in robust and prolonged immunization: Preclinical validation and results of a pilot clinical studies of vaccination for metastatic melanoma. 43
IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes 43
High homogeneity of MAGE, BAGE, GAGE, tyrosinase and melan-A/MART-1 gene expression in clusters of multiple simultaneous metastases of human melanoma: implications for protocol design of therapeutic antigen-specific vaccination strategies 43
The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells 42
Control of the immune system by oxysterols and cancer development 41
Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients 40
IRF1 and NF-kB Restore MHC Class I-Restricted Tumor Antigen Processing and Presentation to Cytotoxic T Cells in Aggressive Neuroblastoma 39
Enzymatic inactivation of oxysterols in breast tumor cells constraints metastasis formation by reprogramming the metastatic lung microenvironment 39
Targeting cholesterol homeostasis in hematopoietic malignancies 38
hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC 37
Functional Heterogeneity of HLA-A*02 Subtypes Revealed by Presentation of a MAGE-3-Encoded Peptide to Cytotoxic T Cell Clones. 37
IL-7 AND IL-15 ALLOW THE GENERATION OF SUICIDE GENE-MODIFIED ALLOREACTIVE SELF-RENEWING CENTRAL MEMORY HUMAN T LYMPHOCYTES. 37
Fate mapping and scRNA sequencing reveal origin and diversity of lymph node stromal precursors 36
Peptide-based vaccines for cancer therapy 34
LXR-dependent and -independent effects of oxysterols on immunity and tumor growth 33
Oxysterols act as promiscuous ligands of class-A GPCRs: In silico molecular modeling and in vitro validation 32
Molecular dissection of the migrating posterior lateral line primordium during early development in zebrafish 32
Therapeutic Regeneration of Lymphatic and Immune Cell Functions upon Lympho-organoid Transplantation 32
Metabolism, LXR/LXR ligands, and tumor immune escape 31
Comprehensive Genomic Characterization of Cutaneous Malignant Melanoma Cell Lines Derived from Metastatic Lesions by Whole-Exome Sequencing and SNP Array Profiling 29
Functional Heterodimerization between the G Protein-Coupled Receptor GPR17 and the Chemokine Receptors 2 and 4: New Evidence 25
Enhancing the Efficacy of Melanoma Treatment: The In Vitro Chemosensitising Impact of Vipera ammodytes Venom on Human Melanoma Cell Lines 23
Continuous Rhythm Monitoring With Implanted Loop Recorders in Children and Adolescents With Brugada Syndrome 3
Primary melanoma of the gastrointestinal tract 2
Totale 4.948
Categoria #
all - tutte 22.109
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.109


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202224 0 0 0 12 3 0 1 3 2 2 0 1
2022/2023165 75 34 13 0 0 17 6 11 4 0 0 5
2023/2024117 7 10 15 12 8 13 8 7 5 3 6 23
2024/2025781 73 9 2 11 21 33 64 53 119 218 70 108
2025/20263.850 300 425 380 613 330 129 259 304 995 115 0 0
Totale 4.948